Cargando…

Mediators of Fibrosis

Detalles Bibliográficos
Autor principal:	Trojanowska, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395879/ https://www.ncbi.nlm.nih.gov/pubmed/22802903 http://dx.doi.org/10.2174/1874312901206010070

Ejemplares similares

The Role of TGF-β Receptors in Fibrosis
por: Nakerakanti, Sashidhar, et al.
Publicado: (2012)

Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosis
por: Stawski, Lukasz, et al.
Publicado: (2012)

Active roles of dysfunctional vascular endothelium in fibrosis and cancer
por: Hsu, Tien, et al.
Publicado: (2019)

Connective Tissue Growth Factor: A Key Factor Among Mediators of Tissue Fibrosis
por: Sheibani, Nader
Publicado: (2022)

Fibrosis
por: Pernia Marin, Monica, et al.
Publicado: (2023)

Hepatitis C and pulmonary fibrosis: Hepatitis C and pulmonary fibrosis
por: Aliannejad, Rasoul, et al.
Publicado: (2011)

Autophagy in Idiopathic Pulmonary Fibrosis: Predisposition of the Aging Lung to Fibrosis?
por: Zmijewski, Jaroslaw W., et al.
Publicado: (2022)

Cystic fibrosis in Brazil: achievements in survival
por: Vendrusculo, Fernanda Maria, et al.
Publicado: (2021)

ATP12A: Connecting Mucus and Fibrosis in Idiopathic Pulmonary Fibrosis
por: Zabner, Joseph, et al.
Publicado: (2023)

Electrocardiogram in Endomyocardial Fibrosis
por: Tharakan, Jaganmohan A
Publicado: (2011)

Klotho and Renal Fibrosis
por: Zununi Vahed, Sepide, et al.
Publicado: (2013)

Combating Kidney Fibrosis
por: Kanasaki, Keizo, et al.
Publicado: (2014)

Flu and pulmonary fibrosis
por: Sharma, Bharat Bhushan, et al.
Publicado: (2013)

Unleashing rapamycin in fibrosis
por: Hillel, Alexander T., et al.
Publicado: (2015)

Cystic fibrosis revisited
por: Kulkarni, H, et al.
Publicado: (2019)

MMP-12 Deficiency Attenuates Angiotensin II-Induced Vascular Injury, M2 Macrophage Accumulation, and Skin and Heart Fibrosis
por: Stawski, Lukasz, et al.
Publicado: (2014)

Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model
por: Lu, Shiping, et al.
Publicado: (2021)

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry
por: Thompson, Cassandra, et al.
Publicado: (2023)

Stem Cells, Inflammation, and Fibrosis
por: Volarevic, Vladislav, et al.
Publicado: (2016)

The stromal fibrosis in aging ovary
por: Umehara, Takashi, et al.
Publicado: (2018)

The Fibrosis Burden of Systemic Sclerosis
por: Keane, Michael P.
Publicado: (2019)

Is it important to quantify hepatic fibrosis?
por: Kohli, Anirudh
Publicado: (2019)

Clinical Advances in Cystic Fibrosis
por: Imperlini, Esther, et al.
Publicado: (2022)

Cystic Fibrosis: “Ionocyte Modulators”?
por: Shah, Viral S., et al.
Publicado: (2023)

The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
por: Maetz, Jessica, et al.
Publicado: (2021)

Telomere Shortening Is behind the Harm of Immunosuppressive Therapy in Idiopathic Pulmonary Fibrosis
por: Molina-Molina, Maria
Publicado: (2019)

A New Era for Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trials in Infants
por: Wainwright, Claire E.
Publicado: (2022)

Noncystic fibrosis bronchiectasis: Is it an orphan disease?
por: Mobaireek, Khalid F.
Publicado: (2007)

Renal Denervation to Treat Cardiac Fibrosis?
por: Wehner, Paulette, et al.
Publicado: (2014)

Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis
por: Zheng, Shirong, et al.
Publicado: (2016)

Idiopathic pulmonary fibrosis: moving forward
por: Richeldi, Luca
Publicado: (2015)

DOCK-t(w)o Pleural Fibrosis
por: Cui, Huachun, et al.
Publicado: (2021)

Chronic Fibrosis and Its Progression to Cancer
por: Yasuma, Taro, et al.
Publicado: (2022)

Pulmonary Fibrosis in the Time of COVID-19
por: Buendia-Roldan, Ivette, et al.
Publicado: (2022)

The Impact of COVID-19 in Cystic Fibrosis
por: Flume, Patrick A., et al.
Publicado: (2022)

Targeting Danger Signals to Rescue Fibrosis
por: Tsoyi, Konstantin, et al.
Publicado: (2022)

State of the Art in Idiopathic Pulmonary Fibrosis
por: El Agha, Elie, et al.
Publicado: (2022)

Demystifying the Enigmatic Fibroblast in Pulmonary Fibrosis
por: Zhou, Yong, et al.
Publicado: (2023)

Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing
por: Hoppe, Jordana E., et al.
Publicado: (2022)

Scoring tools to monitor risk of disease progression in patients with cystic fibrosis
por: Donadio, Márcio Vinícius Fagundes, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q5kahvpd7j6uh4o209padlfun9